(Q50885377)

24 March 2018

review article

1 reference

title

Megatrials of hormonal replacement therapy. (English)

1 reference

24 March 2018

author name string

B G Wren

series ordinal

1

1 reference

24 March 2018

publication date

1 May 1998

1 reference

24 March 2018

published in

Drugs & Aging

1 reference

24 March 2018

volume

12

1 reference

24 March 2018

issue

5

1 reference

24 March 2018

page(s)

343-348

1 reference

24 March 2018

https://scigraph.springernature.com/pub.10.2165/00002512-199812050-00001

exact match

0 references

cites work

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1 reference

12 December 2020

Hormone-replacement therapy and the risk of breast cancer

1 reference

12 December 2020

Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI

1 reference

12 December 2020

Estrogens and Endometrial Cancer in a Retirement Community

1 reference

12 December 2020

A prospective study of postmenopausal estrogen therapy and coronary heart disease

1 reference

12 December 2020

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

12 December 2020

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

12 December 2020

Physiological action of progesterone in target tissues

1 reference

12 December 2020

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

12 December 2020

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

12 December 2020

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

12 December 2020

The effect of oestrogen on the female cardiovascular system

1 reference

12 December 2020

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men

1 reference

12 December 2020

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

12 December 2020

Women's health initiative

1 reference

12 December 2020

Endometrial cancer and estrogen use. Report of a large case-control study

1 reference

12 December 2020

Noncontraceptive estrogen use and cardiovascular disease

1 reference

12 December 2020

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Postmenopausal estrogen use and coronary atherosclerosis

1 reference

12 December 2020

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

12 December 2020

10.2165/00002512-199812050-00001

Identifiers

DOI

1 reference

24 March 2018

Dimensions Publication ID

1010158502

0 references

1 reference

24 March 2018